Literature DB >> 18720417

Poly(methyl methacrylate)-grafted chitosan microspheres for controlled release of ampicillin.

Radhakumary Changerath1, Prabha D Nair, Suresh Mathew, C P Reghunadhan Nair.   

Abstract

Microspheres of 50-500 microm diameter were prepared from a blend of chitosan and chitosan-g-PMMA. Environmental scanning electron microscopic and SEM studies revealed that the microspheres are porous and the pores extend toward the inner core of the microspheres. The microspheres were also found to be hemocompatible and cytocompatible. A model drug ampicillin was used to evaluate the drug loading capacity and the controlled release properties of the microspheres. The system maintained a sustained release of ampicillin for a period of more than 8 days. The drug-loaded chitosan/chitosan-g-PMMA microspheres exhibited higher antibacterial activity for both the gram positive (ATCC 25923 S. aureus) and gram negative (ATCC 25922 E. coli) bacteria than the drug-loaded virgin chitosan microspheres. The percentage release and bioactivity of ampicillin was found to be higher for the chitosan/chitosan-g-PMMA microspheres than the virgin chitosan microspheres. Potential applications such as oral drug delivery, wound dressings, tissue engineering, and so forth, are envisaged from these microspheres.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18720417     DOI: 10.1002/jbm.b.31188

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  2 in total

1.  An in vitro release study of indomethacin from nanoparticles based on methyl methacrylate/glycidyl methacrylate copolymers.

Authors:  L E Nita; A P Chiriac; M Nistor
Journal:  J Mater Sci Mater Med       Date:  2010-11-03       Impact factor: 3.896

2.  Synthesis and Characterization of Stimuli-Responsive Poly(2-dimethylamino-ethylmethacrylate)-Grafted Chitosan Microcapsule for Controlled Pyraclostrobin Release.

Authors:  Chunli Xu; Lidong Cao; Pengyue Zhao; Zhaolu Zhou; Chong Cao; Feng Zhu; Fengmin Li; Qiliang Huang
Journal:  Int J Mol Sci       Date:  2018-03-14       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.